Related Experiment Videos

Mitral valve replacement with a turtleneck-disc prosthesis

Insights

This study evaluated the Harken (Magovern) disc valve in 100 patients over 5 years. While operative mortality was low, late deaths were higher in severe heart failure patients and those with multiple valve replacements.

Area of Science:

  • Cardiovascular Surgery
  • Biomaterials Science
  • Clinical Outcomes Research

Background:

  • The Magovern-Harken valve is a specific type of prosthetic heart valve.
  • Continuous suture techniques are employed for valve implantation.
  • Long-term outcomes of prosthetic valves are crucial for patient management.

Purpose of the Study:

  • To report the 5-year experience with the Magovern-Harken disc valve in 100 patients.
  • To analyze factors influencing operative and late mortality.
  • To assess the incidence of thromboembolic complications and valve-related issues.

Main Methods:

  • Prospective evaluation of 100 patients receiving the Magovern-Harken valve.
  • Implantation via continuous suture technique in the atrioventricular position.
  • Follow-up for 5 years to assess mortality, complications, and valve function.

Main Results:

  • Operative mortality was 7%, and late mortality was 8%.
  • Factors like age, pulmonary hypertension, and reoperation did not affect operative mortality.
  • Late mortality was significantly higher in New York Heart Association Class IV patients and those undergoing multiple valve replacements.
  • Thromboembolic complications occurred in 7% of patients; no peribasilar leaks or dehiscences were observed.

Conclusions:

  • The Magovern-Harken disc valve demonstrates acceptable early and late survival rates.
  • Patient functional status and the extent of valve surgery are critical determinants of long-term outcomes.
  • The valve appears safe regarding peribasilar complications, with a manageable rate of thromboembolic events.

Related Concept Videos